METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
Reconstituted storage After reconstitution with bacteriostatic water, store the vial at 2-8C (35.6-46.4F)
Improved Muscle Healing and Recovery from Strain While muscle heals faster than tendon, BPC-157 helps accelerate: Muscle fiber regeneration (especially in grade III tears) Satellite cell activation for muscle repair Local capillary density and oxygen delivery post-injury Athletes report: Shorter time to return to full training load Less stiffness and pain post-injury Improved contractile function in previously strained muscle groups This makes BPC-157 ideal during deload phases, post-surgery rehab, or sports-related soft tissue trauma
Patients commonly notice some gradually increasing migraines 1-2 weeks or so before getting to the 3-month wear-off window
Intraperitoneale Einzelverabreichung von NaBPC157 in Form einer Vorbehandlung fhrte zur Prvention der elektrokardiographisch gezeigten Ischmie und der histologischen Myokardschdigung whrend des Immobilisierungsstresstests
